Research
Print page Print page
Switch language
The Capital Region of Denmark - a part of Copenhagen University Hospital
Published

The Pharmacopsychometric Triangle to Illustrate the Effectiveness of T-PEMF Concomitant with Antidepressants in Treatment Resistant Patients: A Double-Blind, Randomised, Sham-Controlled Trial Revisited with Focus on the Patient-Reported Outcomes

Research output: Contribution to journalJournal articleResearchpeer-review

DOI

  1. Seasonal variation in neurohormones, mood and sleep in patients with primary open angle glaucoma - implications of the ipRGC-system

    Research output: Contribution to journalJournal articleResearchpeer-review

  2. Light therapy for seasonal affective disorder in visual impairment and blindness - a pilot study

    Research output: Contribution to journalJournal articleResearchpeer-review

  3. Reducing the rate of psychiatric Re-ADMISsions in Bipolar Disorder using smartphones The RADMIS trial

    Research output: Contribution to journalJournal articleResearchpeer-review

  4. Melanopsin-mediated pupillary responses in bipolar disorder-a cross-sectional pupillometric investigation

    Research output: Contribution to journalJournal articleResearchpeer-review

View graph of relations
Background. Our T-PEMF trial has been revisited with focus on the pharmacopsychometric triangle in which effect size is used when comparing wanted versus unwanted clinical effects and quality of life as outcomes. In this analysis, we have especially focused on the self-reported HAM-D(6). Methods. The antidepressive medication which the patients were resistant to was kept unchanged during the five weeks of active versus sham T-PEMF. Results. In total 21, patients received active T-PEMF, and 19 patients received sham T-PEMF. The effect size was 1.02 and 0.90, respectively, on HAM-D(6) and HAM-D(6)-S. Concerning side effects, the active T-PEMF reduced the baseline score on concentration problems with an effect size of 0.44 while inducing more autonomic symptoms than sham T-PEMF with an effect size of -0.41. The advantage of active over sham T-PEMF obtained an effect size of 0.48. Conclusion. Active T-PEMF was found superior to sham T-PEMF within the pharmacopsychometric triangle with a clinically significant effect size level above 0.40.
Original languageEnglish
JournalDepression Research and Treatment
Volume2011
Pages (from-to)806298
ISSN2090-1321
DOIs
Publication statusPublished - 2011

ID: 34718443